Showing results (281-290 of 341) with videos related to

Sort By:
Pageof 35
Journal of Viral Hepatitis|February 3, 2021
Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like GroupYu-Ju Wei, Po-Yao Hsu, Jia-Jung Lee, et al.
American Journal of Cancer Research|January 11, 2023
Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinomaPo-Yao Hsu, Po-Cheng Liang, Wen-Tsan Chang, et al.
Clinical and Molecular Hepatology|October 4, 2023
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseasesPin-Nan Cheng, Wen-Jone Chen, Charles Jia-Yin Hou, et al.
Cancer Medicine|November 17, 2021
Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levelsPo-Yao Hsu, Tzu-Sheng Cheng, Shih-Chang Chuang, et al.
Scientific Reports|April 21, 2021
Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in TaiwanMing-Ying Lu, Chun-Ting Chen, Yu-Lueng Shih, et al.
Hepatology Communications|January 13, 2021
Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular CarcinomaVincent L Chen, Ming-Lun Yeh, Ju Dong Yang, et al.
The Journal of Infectious Diseases|May 17, 2021
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis BYao-Chun Hsu, Ming-Lun Yeh, Grace Lai-Hung Wong, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 2, 2024
Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis CChun-Ming Hong, Tung-Hung Su, Shih-Jer Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2024
Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular CarcinomaDaniel Q Huang, Joseph K Hoang, Rubayet Kamal, et al.
Scientific Reports|June 18, 2017
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C PatientsMei-Hsuan Lee, Chung-Feng Huang, Hsueh-Chou Lai, et al.
Pageof 35